Dr. Ankur BAHL

Dr. Ankur Bahl is a medical oncologist with more than 15 years of experience in cancer care. He completed his MBBS and MD in Medicine at Maulana Azad Medical College, New Delhi, and went on to earn a DM in Medical Oncology from the All India Institute of Medical Sciences (AIIMS), New Delhi. He has also undertaken training at the University of Oxford in adverse drug reactions, drug interactions and pharmacovigilance, supporting his work in the safe and evidence-based use of cancer treatments.

His clinical interests include the management of solid tumours and blood cancers, with particular experience in head and neck cancer, lung cancer, breast cancer, lymphoma, leukaemia, pancreatic cancer and gynaecological tumours. His treatment expertise includes immunotherapy, targeted therapy, chemotherapy, hormonal therapy, and supportive and palliative care. The supplied information also highlights his involvement in bone marrow transplantation and in the use of targeted therapies for head and neck cancer.

Dr. Bahl has contributed to oncology research and education, including work on targeted therapy with cetuximab in head and neck cancer, acute myeloid leukaemia treatment, and human papillomavirus (HPV) trends in the Indian population. He has helped establish national and international educational initiatives for oncology professionals, including evidence-based debates, live tumour boards, master classes and workshops. He has also participated in professional guidance for oncology fellows and students and in no-tobacco awareness workshops for school students.

He is currently associated with Fortis Memorial Research Institute (FMRI), Gurugram, where he continues his work in medical oncology. Before joining FMRI, he served as Director of Medical Oncology and Haematology-Oncology at Max Hospital, Saket, and was also associated with Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.

Educational Qualifications

• MBBS — Maulana Azad Medical College, New Delhi (2003).
• MD in Medicine — Maulana Azad Medical College, New Delhi (2007).
• DM in Medical Oncology — All India Institute of Medical Sciences (AIIMS), New Delhi (2012).
• Training in adverse drug reactions, drug interactions and pharmacovigilance — University of Oxford, United Kingdom.

Fellowship & Areas of Interest

• Clinical interests include medical oncology, haematological malignancies, solid tumours, immunotherapy, targeted therapy, chemotherapy, hormonal therapy, and supportive and palliative care.
• Areas of focus include head and neck cancer, lung cancer, breast cancer, pancreatic cancer, gynaecological tumours, lymphoma, leukaemia and bone marrow transplantation.

Research Contributions & Publications

• Lead author of reported Indian real-world data on cetuximab-based targeted therapy in head and neck cancer.
• Research contributions include acute myeloid leukaemia treatment and HPV trends in the Indian population.
• Reported to have published in national and international journals and books.

Awards, Honours, and Recognitions

• Dr. Rehan Gold Medal for being the top outgoing postgraduate student in Internal Medicine at Delhi University.
• Contributor to national and international oncology education initiatives, including live tumour boards, evidence-based debates, master classes and workshops.

​​​​​​​Specialization

• Medical Oncology
• Solid tumours and haematological malignancies
• Head and neck, lung, breast and pancreatic cancers
• Lymphoma, leukaemia and gynaecological tumours
• Immunotherapy, targeted therapy, chemotherapy, hormonal therapy, and supportive and palliative care

• Principal current association: Fortis Memorial Research Institute (FMRI), Gurugram — Medical Oncology.
• Previously Director of Medical Oncology and Haematology-Oncology at Max Hospital, Saket, New Delhi.
• Previous associations include Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.